CareRx
TSX:CRRX
C$ 3,82
C$-0,05 (-1,29%)
3,82 C$
C$-0,05 (-1,29%)
End-of-day quote: 03/25/2026

CareRx Stock Value

The current analyst rating for CareRx is Buy.
Buy
Buy

CareRx Company Info

EPS Growth 5Y
14,98%
Market Cap
C$0,24 B
Long-Term Debt
C$0,04 B
Short Interest
0,00%
Quarterly earnings
05/07/2026 (E)
Dividend
C$0,08
Dividend Yield
2,07%
Founded
2001
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

C$5,38
40.84%
40.84
Last Update: 03/22/2026
Analysts: 6

Highest Price Target C$6,25

Average Price Target C$5,38

Lowest Price Target C$4,50

In the last five quarters, CareRx’s Price Target has risen from C$2,69 to C$3,73 - a 38,66% increase. One analysts predict that CareRx’s share price will increase in the coming year, reaching C$5,38. This would represent an increase of 40,84%.

Top growth stocks in the consumer discretionary sector (5Y.)

What does CareRx do?

CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings. Business Segments The company operates primarily within the institutional pharmacy business segment. This segment encompasses several operating units that provide a range of pharmacy services tailored to the needs of long-term care facilities. The company’s institutional pharmacy services include medication dispensing, medication therapy management, and comprehensi...
×